EBIT: Income before interest and taxes.
REGENXBIO Inc. (RGNX) had EBIT of $-161.20M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$170.44M |
|
$-193.88M |
|
$20.30M |
|
$150.14M |
|
$331.64M |
|
$-161.20M |
|
$-32.68M |
|
$-193.88M |
|
$-193.88M |
|
$-193.88M |
|
$-193.88M |
|
$-193.88M |
|
$-193.88M |
|
|
EBIT |
$-161.20M |
$-161.20M |
|
51.57M |
|
51.57M |
|
$-3.76 |
|
$-3.76 |
|
| Balance Sheet Financials | |
$281.28M |
|
$104.86M |
|
$171.75M |
|
$453.03M |
|
$118.09M |
|
-- |
|
$232.20M |
|
$350.30M |
|
$102.73M |
|
$102.73M |
|
$102.73M |
|
50.89M |
|
| Cash Flow Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|